Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer.

REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...

REYKJAVIK, Iceland, May 10, 2021 /PRNewswire/ -- In a study published today, scientists at deCODE Genetics demonstrate for the first time howlong-read DNA sequencing can be applied at population ...

REYKJAVIK, Iceland, Jan. 8, 2021 /PRNewswire/ -- In the article, Differences between germline genomes of monozygotic twins, published in Nature Genetics today scientists at deCODE genetics ...

News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.

LONDON, April 15 (Reuters) - The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. .

Now, a large international study led by deCODE Genetics (a subsidiary of Amgen) provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine ...

NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics' Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing CAMBRIDGE, ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

DeCode scientists reported yesterday that people who inherit two copies of the gene – one from each parent – are more than twice as likely to develop diabetes as those who don’t carry any copies.